publicações selecionadas
-
artigo académico
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma - in final phase of preparation 2026
- Glutaminase 1 (GLS1)-based therapy targets glutamine reliance in glioblastoma (GBM) 2026
- Hijacking of neural circuits by malignant glioma: mechanistic insights and clinical implications 2026
- Metabolic symbioses between glioblastoma and immune cells: a special focus on microglia and macrophages - in final phase of preparation 2026
- WNT6 drives mechanisms of aggressiveness and resistance to chemotherapy in human glioblastoma - in final phase of preparation 2026
- Improving neuroblastoma therapy with a new p53 family-activating agent. European Journal of Pharmacology. 2025
- Updating TCGA glioma classification through integration of molecular data following the latest WHO guidelines. Scientific Data. 2025
- A novel tool for multi-omics network integration and visualization: A study of glioma heterogeneity. Computers in Biology and Medicine. 2025
- Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival. Cancers. 2024
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma 2024
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma - in final phase of preparation 2024
- WNT6 drives mechanisms of aggressiveness and resistance to chemotherapy in human glioblastoma - in final phase of preparation 2024
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular Oncology. 2022
- Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma. Frontiers in Oncology. 2022
- Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness. Translational Research. 2022
- The Role of Network Science in Glioblastoma. Cancers. 2021
- Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma. Cancers. 2021
- Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo. International Journal of Applied Pharmaceutics. 2021
- A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Molecular Oncology. 2020
- WNT6 is a Novel Oncogenic Prognostic Biomarker in Human Glioblastoma. Theranostics. 2018
-
documento
- P01.23.A Cadherin-3-mediated metabolic reprogramming and prognostic stratification in glioblastoma 2025
- P12.08.A Deciphering WNT6-driven mechanims of aggressiveness and resistance to chemotherapy in human glioblastoma 2025
- Relevance of WNT6 in Extracellular Vesicles of Glioblastoma: Clinical and Molecular Insights 2024
- MINGLE: a new tool for advancing multi-omics network integration and visualization 2024
- MINGLE: A new tool for advancing multi-omics netwrok integration and visualization 2024
- Deciphering WNT6-driven mechanisms of aggressiveness and resistance to chemotherapy in human glioblastoma 2024
- Exploiting the Relevance of WNT6 in Extracellular Vesicles of Glioblastoma: Clinical and Molecular Insights 2024
- Abstract 1770 Targeting glutamine availability with glutaminase 1-based glioblastoma therapy 2024
- Deciphering novel mechanisms of WNT6-driven chemotherapy resistance in human glioblastoma 2023
- Emerging roles of the critical oncogenic molecule Cadherin-3 in glioblastoma 2023
- Unveiling the impact of the oncogenic molecule Cadherin-3 in the metabolism of human glioblastoma 2023
- A transcriptomic profiling reveals novel roles of Cadherin-3 in metabolic programming of glioblastoma 2023
- Unveiling the impact of the oncogenic molecule Cadherin-3 in themetabolism of human glioblastoma 2023
- Role of the ubiquitin hydrolase ATXN3 in glioblastoma: a new tumor suppressor gene? 2022
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma 2022
- CDH3/P-cadherin is a novel oncogenic biomarker with prognostic value in glioblastoma 2020
- Deciphering WNT6 up and down roads in glioblastoma: mechanistic, functional, and clinical insight 2020
- Functional and prognostic relevance of CDH3/P-cadherin in glioblastoma 2019
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma 2019
- Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights 2019
- CDH3/P-cadherin is an oncogenic biomarker in glioblastoma 2019
- CDH3/P-cadherin as a novel biomarker in gliomas: mechanistic, functional and prognostic insights 2018
- PO-473 Wnt6 expression in glioblastoma: mechanistic, functional and clinical implications 2018
- CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma 2018
- CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- Functional impact and prognostic relevance of CDH3/P-cadherin in glioblastoma 2018
- PO-105 Cdh3/p-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance 2017
- A Novel Tool for Multi-Omics Network Integration and Visualization: A Study of Glioma Heterogeneity
- Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelines
-
teses